Shareholders Equity: The sum of preferred and common equity items.
Quantum Biopharma Ltd. (QNTM) had Shareholders Equity of $7.51M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.32M |
|
-- |
|
-- |
|
$4.68M |
|
$-4.68M |
|
$-0.07M |
|
$-4.75M |
|
$-4.89M |
|
$-4.75M |
|
$-4.75M |
|
$-4.75M |
|
$-4.89M |
|
$-4.68M |
|
$-4.53M |
|
3.80M |
|
3.80M |
|
$-1.25 |
|
$-1.25 |
|
| Balance Sheet Financials | |
$9.34M |
|
$0.07M |
|
$4.81M |
|
$14.15M |
|
$6.65M |
|
-- |
|
-- |
|
$6.65M |
|
$7.51M |
|
$2.89M |
|
|
Shareholders Equity |
$7.51M |
3.82M |
|
| Cash Flow Statement Financials | |
$-7.93M |
|
$-2.30M |
|
$4.68M |
|
$6.00M |
|
$0.45M |
|
$-5.55M |
|
$2.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.41 |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-63.24% |
|
-164.42% |
|
-33.54% |
|
-63.24% |
|
$1.97 |
|
$-2.09 |
|
$-2.09 |
|